Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04872400 · ClinicalTrials.gov registry record · Phase 4
Acute Application of Antibiotic Powder in Open Fracture Wounds
A Phase 4 study, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
NCT04872400 is a Phase 4 study that has completed, run by University of Colorado, Denver. The registered enrollment target is 20 participants.
The verdict
NCT04872400, a Phase 4 study, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to help determine the best treatment for severe injures like open fracture wounds. Some broken bone injuries can be more likely to get an infection. It is mostly due to the way they were injured. Surgical site infection in the orthopedic surgery population is a big public health issue. Wound infections result in both longer length of hospital stay and total cost of care. This study will be using an antibiotic called Vancomycin or Tobramycin in a powder form.
Interventions
- DRUG Vancomycin
- DRUG Tobramycin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2021-06-14 |
| Est. Completion | 2023-09-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04872400
The ClinicalTrials.gov registry entry for NCT04872400 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vancomycin is the first listed.
NCT04872400 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04872400 about?
NCT04872400 is a clinical study titled "Acute Application of Antibiotic Powder in Open Fracture Wounds". The purpose of this study is to help determine the best treatment for severe injures like open fracture wounds. Some broken bone injuries can be more likely to get an infection. It is mostly due to the way they were injured. Surgical site infection in the orthopedic surgery population is a big publ...
What is the current status of trial NCT04872400?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2021-06-14. Estimated completion is 2023-09-30.
What interventions are being tested in trial NCT04872400?
The interventions under investigation include: Vancomycin (DRUG), Tobramycin (DRUG).
Who is sponsoring clinical trial NCT04872400?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.